Nation's testing czar: It's 'time to move on' from talk about hydroxychloroquine

This version of Nation S Testing Czar It S Time Move Talk About N1235600 - Politics and Government | NBC News Clone was adapted by NBC News Clone to help readers digest key facts more efficiently.

Brett Giroir says emphasis should be on "effective" ways to curb the virus despite Trump's continued promotion of hydroxychloroquine.
Get more newsNation S Testing Czar It S Time Move Talk About N1235600 - Politics and Government | NBC News Cloneon

WASHINGTON — Dr. Brett Giroir, who coordinates the Trump administration's coronavirus testing response, said Sunday that there is no evidence that hydroxychloroquine is an "effective" treatment for COVID-19, despite President Donald Trump's repeated boosting of the drug over objections from experts.

In an interview on "Meet the Press," Giroir, the assistant secretary of health and human services for health, did not specifically mention the president, but he it made clear that the scientific consensus is that the drug does not help treat the disease.

"Most physicians and prescribers are evidence-based, and they're not influenced by whatever is on Twitter or anything else. And the evidence just does not show hydroxychloroquine is effective right now," he said.

"We need to move on from that and talk about what is effective," he added, pointing to public hygiene measures like hand-washing and mask-wearing, as well as treatments like the drug remdesivir and steroids.

"At this point in time, there has been five randomized controlled, placebo-controlled trials that do not show any benefit to hydroxychloroquine. So, at this point in time, we don't recommend that as a treatment."

Since the early days of the pandemic, Trump has promoted his belief that hydroxychloroquine, an anti-malarial drug, could help treat the disease. In May, he said he had taken the unproven treatment for two weeks prophylactically.

While the Food and Drug Administration briefly issued the drug an emergency use authorization that allowed it to be used as treatment for COVID-19, it withdrew the authorization in June. In removing the authorization, it pointed to "a large, randomized clinical trial in hospitalized patients that found these medicines showed no benefit for decreasing the likelihood of death or speeding recovery."

Despite similar statements from public health officials, as well as an FDA warning against using the drug outside a hospital setting because of a risk of serious heart problems, Trump has remained steadfast in boosting of the drug.

Last week, Trump retweeted a video of a Houston-area doctor arguing in favor of using the drug and calling it a cure for the coronavirus. Twitter removed the video as a "violation of our COVID-19 misinformation policy," and Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said the video was "spouting something that isn't true."

Trump defended his decision to share the video during a White House briefing, saying, "I happen to believe in it." He was later pressed to answer for the doctor's past statements, which include blaming certain medical problems on demonic possession.

"She was on air along with many other doctors," Trump said. "They were being fans of hydroxychloroquine, and I thought she was very impressive in the sense that — from where she came, I don't know which country she comes from — but she said that she's had tremendous success with hundreds of different patients, and I thought her voice was an important voice. But I know nothing about her."

AdBlock Detected!
Please disable it to support our content.
×

Related Articles

Donald Trump Presidency Updates - Politics and Government | NBC News Clone | Joe Biden Campaign News - Politics and Government | NBC News Clone | Kamala Harris Vp Announcement - Politics and Government | NBC News Clone | Trump Indictment Latest - Politics and Government | NBC News Clone | Election Results Live - Politics and Government | NBC News Clone | Swing States Polling - Politics and Government | NBC News Clone | Debate Highlights - Politics and Government | NBC News Clone | Budget Approval 2025 - Politics and Government | NBC News Clone | Abortion Ruling - Politics and Government | NBC News Clone | Us China Relations - Politics and Government | NBC News Clone | Inflation Rates 2025 Analysis - Business and Economy | NBC News Clone | Federal Reserve Interest Rates - Business and Economy | NBC News Clone | Stock Market Today - Business and Economy | NBC News Clone | Recession Prediction 2025 - Business and Economy | NBC News Clone | Jobs Report Unemployment - Business and Economy | NBC News Clone | Ai Stock Surge - Business and Economy | NBC News Clone | Housing Market Crash - Business and Economy | NBC News Clone | Oil Prices Update - Business and Economy | NBC News Clone | Amazon Prime Sales - Business and Economy | NBC News Clone | Bitcoin Etf Approval - Business and Economy | NBC News Clone | Latest Vaccine Developments - Health and Medicine | NBC News Clone | Covid Variants Update - Health and Medicine | NBC News Clone | Boosters New Guidelines - Health and Medicine | NBC News Clone | Anxiety Depression Treatment - Health and Medicine | NBC News Clone | Longevity Research - Health and Medicine | NBC News Clone | Diet Trends 2025 - Health and Medicine | NBC News Clone | Workout Routines - Health and Medicine | NBC News Clone | Fda Approvals 2025 - Health and Medicine | NBC News Clone | Ukraine Russia Conflict Updates - World News | NBC News Clone | Israel Palestine War News - World News | NBC News Clone | China Taiwan Tensions - World News | NBC News Clone | Middle East Peace Talks - World News | NBC News Clone | European Union Politics - World News | NBC News Clone | Development News - World News | NBC News Clone | North Korea Missile Test - World News | NBC News Clone | Brazil Election - World News | NBC News Clone | Openai Chatgpt News - Technology and Innovation | NBC News Clone | Google Bard Ai - Technology and Innovation | NBC News Clone | Ai Regulation Laws - Technology and Innovation | NBC News Clone | Tiktok Ban Update - Technology and Innovation | NBC News Clone | Data Breaches 2025 - Technology and Innovation | NBC News Clone | Iphone 16 Release - Technology and Innovation | NBC News Clone | Nasa Mars Mission - Technology and Innovation | NBC News Clone | Web3 Developments - Technology and Innovation | NBC News Clone | 2024 Paris Games Highlights - Sports and Recreation | NBC News Clone | Super Bowl 2025 Preview - Sports and Recreation | NBC News Clone | Nba Playoffs 2025 - Sports and Recreation | NBC News Clone | Champions League Finals - Sports and Recreation | NBC News Clone | World Series 2025 - Sports and Recreation | NBC News Clone | Masters Tournament 2025 - Sports and Recreation | NBC News Clone | Extreme Weather Events - Weather and Climate | NBC News Clone | Hurricane Season 2025 - Weather and Climate | NBC News Clone | Global Warming Report - Weather and Climate | NBC News Clone | Weekly Weather Update - Weather and Climate | NBC News Clone | Earthquake Alerts - Weather and Climate | NBC News Clone | Solar Storm Warning - Weather and Climate | NBC News Clone | Hollywood Updates - Entertainment and Celebrity | NBC News Clone | Oscar Nominations 2025 - Entertainment and Celebrity | NBC News Clone | Grammy Awards 2025 - Entertainment and Celebrity | NBC News Clone | Netflix New Releases - Entertainment and Celebrity | NBC News Clone | Video Game Releases - Entertainment and Celebrity | NBC News Clone | Bestseller List - Entertainment and Celebrity | NBC News Clone | Government Transparency - Investigations and Analysis | NBC News Clone | Political Corruption - Investigations and Analysis | NBC News Clone | Big Tech Monopoly - Investigations and Analysis | NBC News Clone | Data Privacy Scandal - Investigations and Analysis | NBC News Clone | Community Stories - Local News and Communities | NBC News Clone | Nyc Mayor News - Local News and Communities | NBC News Clone | La Wildfires Update - Local News and Communities | NBC News Clone | Hurricane Preparedness - Local News and Communities | NBC News Clone